CIK 0001412486 · Non-accelerated filer<br>Smaller reporting company
Cocrystal Pharma, Inc.
Sign in to watch- Ticker
- COCP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 352528215
- Phone
- (786) 459-1831
- Business address
- 19805 N. CREEK PARKWAY, BOTHELL, WA, 98011
- Former names
- BIOZONE PHARMACEUTICALS, INC., International Surf Resorts, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-05-10 | Schinazi Raymond F Director | Grant or award | +10,209 | $1.90 | $19K | 995,593 |
| 2018-05-10 | Schinazi Raymond F Director | Returned to the company · 8% Convertible Note | −61,728 | $500,000.00 | $30.9B | 61,728 |
| 2018-05-10 | Schinazi Raymond F Director | Grant or award · 8% Convertible Note | +263,158 | $500,000.00 | $131.6B | 263,158 |
| 2018-05-10 | Schinazi Raymond F Director | Option exercise · 8% Convertible Note | −263,158 | $500,000.00 | $131.6B | 263,158 |
| 2018-05-03 | Schinazi Raymond F Director | Grant or award | +420,737 | $1.90 | $799K | 722,226 |
| 2018-05-03 | FROST PHILLIP MD ET AL Director | Grant or award | +105,263 | $1.90 | $200K | 3,655,265 |
| 2017-11-24 | Schinazi Raymond F Director | Grant or award · 8% Convertible Note | +1,851,851 | $500,000.00 | $925.9B | 1,851,851 |
| 2017-07-11 | Schinazi Raymond F Director | Option exercise | +1,706,978 | $0.05 | $80K | 277,227,831 |
| 2017-07-11 | Schinazi Raymond F Director | Option exercise · Stock Options (Right to Buy) | −1,706,978 | 0 | ||
| 2017-04-20 | Schinazi Raymond F Director | Grant or award | +4,166,667 | $0.24 | $1.0M | 9,044,717 |
| 2016-12-23 | Lee Sam PRESIDENT | Sale | −2,200,000 | $0.44 | $968K | 13,087,847 |
| 2016-09-01 | BLOCK DAVID S Director | Purchase | +10,000 | $0.41 | $4K | 168,696 |
| 2016-09-01 | Schinazi Raymond F Director | Purchase | +4,878,050 | $0.41 | $2.0M | 4,878,050 |
| 2016-09-01 | WILCOX GARY INTERIM CEO | Purchase | +10,000 | $0.41 | $4K | 16,948,605 |
| 2016-03-15 | Rubin Steven D Director | Purchase | +39,216 | $0.51 | $20K | 733,484 |
| 2016-03-15 | FROST PHILLIP MD ET AL Director | Purchase | +2,941,177 | $0.51 | $1.5M | 106,500,147 |
| 2016-03-15 | Meckler Jeffrey A CHIEF EXECUTIVE OFFICER | Purchase | +294,118 | $0.51 | $150K | 657,161 |
| 2016-03-15 | BLOCK DAVID S Director | Purchase | +50,000 | $0.51 | $26K | 158,696 |
| 2016-03-15 | WILCOX GARY Director | Purchase | +49,020 | $0.51 | $25K | 16,938,605 |
| 2016-03-15 | Rubin Steven D Director | Purchase | +39,216 | $0.51 | $20K | 93,564 |
Page 5 of 8 · 145 trades